Real-world use of nirmatrelvir-ritonavir: who benefits?

被引：1
|
作者：
Molina, Kyle C. [1 ,2 ]
Ginde, Adit A. [1 ]
机构：
[1] Colorado Univ, Dept Emergency Med, Sch Med, Aurora, CO 80045 USA
[2] Scripps Hlth, La Jolla, CA 92037 USA
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S1473-3099(23)00180-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [31] The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
    Petrakis, Vasilios
    Rafailidis, Petros
    Trypsianis, Grigorios
    Papazoglou, Dimitrios
    Panagopoulos, Periklis
    VIRUSES-BASEL, 2023, 15 (04):
  • [32] Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19
    Anderson, Annaliesa S.
    Caubel, Patrick
    Rusnak, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1047 - 1049
  • [33] Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy
    Cohen, Myron S.
    Brown, Elizabeth R.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1672 - 1673
  • [34] Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data
    Liu, Ting-Hui
    Huang, Po-Yu
    Wu, Jheng-Yan
    Chuang, Min-Hsiang
    Hsu, Wan-Hsuan
    Tsai, Ya-Wen
    Chang, Chih-Cheng
    Lai, Chih-Cheng
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (05)
  • [35] Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
    Hammond, Jennifer
    Yunis, Carla
    Fountaine, Robert J.
    Luscan, Gerald
    Burr, Aimee M.
    Zhang, Wuyan
    Wisemandle, Wayne
    Soares, Holly
    Baniecki, Mary Lynn
    Hendrick, Victoria M.
    Kalfov, Veselin
    Pypstra, Rienk
    Rusnak, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 224 - 234
  • [36] Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
    Wong, Grace Lai-Hung
    Yip, Terry Cheuk-Fung
    Lai, Mandy Sze-Man
    Wong, Vincent Wai-Sun
    Hui, David Shu-Cheong
    Lui, Grace Chung-Yan
    JAMA NETWORK OPEN, 2022, 5 (12) : e2245086
  • [37] Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study
    Aggarwal, Neil R.
    Molina, Kyle C.
    Beaty, Laurel E.
    Bennett, Tellen D.
    Carlson, Nichole E.
    Mayer, David A.
    Peers, Jennifer L.
    Russell, Seth
    Wynia, Matthew K.
    Ginde, Adit A.
    LANCET INFECTIOUS DISEASES, 2023, 23 (06): : 696 - 705
  • [38] Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir
    Gerhart, Jacqueline
    Draica, Florin
    Benigno, Michael
    Atkinson, Jo
    Reimbaeva, Maya
    Francis, Domenick
    Baillon-Plot, Nathalie
    Sidhu, Gurinder Singh
    Damle, Bharat D.
    AAPS JOURNAL, 2023, 25 (05):
  • [39] Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk
    Paraskevis, Dimitrios
    Gkova, Maria
    Mellou, Kassiani
    Gerolymatos, Gerasimos
    Psalida, Naya
    Gkolfinopoulou, Kassiani
    Kostaki, Evangelia-Georgia
    Loukides, Stylianos
    Kotanidou, Anastasia
    Skoutelis, Athanasios
    Thiraios, Eleftherios
    Saroglou, Georgios
    Zografopoulos, Dimitrios
    Filippou, Dimitrios
    Mossialos, Elias
    Zaoutis, Theoklis
    Gaga, Mina
    Tsiodras, Sotirios
    Antoniadou, Anastasia
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (12): : 1667 - 1674
  • [40] Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study
    Choi, Ming Hong
    Wan, Eric Yuk Fai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    Chu, Wing Ming
    Tam, Anthony Raymond
    Yuen, Kwok Yung
    Hung, Ivan Fan Ngai
    LANCET INFECTIOUS DISEASES, 2024, 24 (11):
12345